Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-011-5 | CAS number: 1072-62-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May - November 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-ethylimidazole
- EC Number:
- 214-011-5
- EC Name:
- 2-ethylimidazole
- Cas Number:
- 1072-62-4
- Molecular formula:
- C5H8N2
- IUPAC Name:
- 2-ethylimidazole
- Details on test material:
- - Name of test material (as cited in study report): 2-Ethylimidazole
- Test item No.: 10/0502-2
- Physical state: Yellowish solid
- Homogeneity: The test item appeared to be homogenous
- Analytical purity: 99.7 corr. area-%
- Lot/batch No.: 60291956P0
- Expiration date of the lot/batch: 08 March 2016
- Storage condition of test material: At room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V. Inc. Postbus 6174 5960 AD Horst / The Netherlands
- Age at study initiation: Pre-test: 11-12 weeks: Main study: 9-10 weeks
- Weight at study initiation: Pre-test: 19.7-20.1g; Main study: 18.4-22.9g
- Housing: grouped by test groups, Makrolon Type II (pre-test) / III (main study), with wire mesh top
- Diet: ad libitum 2018C Teklad Global 18 % protein rodent diet
- Water: ad libitum tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 (except for several hours)
- Humidity (%): 45-65 (except for several hours)
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- 10, 25, 50 %
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: experiment was performed according to the recommendations given by OECD 429
- Irritation: no excessive local skin irritation in 2 animals treated with 25 and 50 % on 3 consecutive days. From day 3 until 5, the animal treated with 50% test item concentration showed a very slight erythema of the ear skin (score 1). In addition, both animals showed substance residues during the course of the study. No signs of excessive local skin irritation or of systemic toxicity were observed.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response:
a) exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at
least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index
b) data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either
local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
- Animals were treated topically on the dorsal surface of each ear (25 μL/ear/day) on 3 consecutive days
- 5 days after first application 78.2 μCi/mL 3HTdR were injected
- 5 h after injection animals were sacrificed - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables, for the ear weights, the lymph node weights and lymph node cell
count, and for the DPM values (group mean DPM ± standard deviation).
A statistical analysis was conducted on the DPM values, the ear weights, the lymph node weights and the lymph node cell count to assess whether the difference was statistically significant between the test item groups and negative control group. For all statistical calculations validated statistical
program R Script DecisionTree_2.Rnw was used. Statistical significance was set at the five per cent level (p < 0.05).
The Dean-Dixon-Test and the Grubb’s test were used for detection of possible outliers (performed with validated statistical program R Script Outlier.Rnw). No outlier was detected.
However, both biological and statistical significance were considered together.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- - Vehicle control: 1.0 - 10 %: 1.06 - 25 %: 1.59 - 50 %: 2.24* *Mean DPM value for the group was significantly higher than the corresponding control value. The p value for the analysis was 0.021. The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Mean DPM per animal (2 lymph nodes) - Vehicle Control Group (MEK): 978.6 +/- 159.4 - 10% 2-Ethylimidazole: 1039.0 +/- 269.6 - 25% 2-Ethylimidazole: 1560.6 +/- 569.7 - 50% 2-Ethylimidazole: 2196.8 +/- 1098.0 Mean DPM/animal was determined by dividing the sum of the measured values from lymph nodes of all animals within a group by the number of animals in that group (5 animals).
Any other information on results incl. tables
Viability / Mortality
No deaths occurred during the study period.
Clinical Signs
No signs of systemic toxicity were observed during the study period. On day 3 and 4, a slight erythema of the ear skin (score 1) was observed in the animals treated with 50% of the test item.
Body Weights
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Lymph Node Weights and Cell Counts
The measured lymph node weights and –cell counts of all animals treated were recorded after sacrifice. A statistically significant but biologically not relevant increase in lymph node weights and –cell counts was observed in the highest dose group in comparison to the vehicle control group. For BALB/c mice, a cut-off value for the lymph node cell count index of 1.55 was reported for a positive response (Ehling et al., 2005). The index determined for the lymph node cell count slightly exceeded this threshold in the high dose group (index of 1.61).
Ear Weights
The measured ear weight of all animals treated was recorded on test day 6 (after necropsy). A biologically relevant or statistically significant increase in ear weights was not observed. Furthermore, the cut-off value (1.1) of the ear weight index for a positive response regarding ear skin irritation reported for BALB/c mice (Ulrich et al., 2001) was not reached or exceeded in any of the treated groups.
References:
Ehling G., Hecht, M., Heusener J., Gamer A.O., van Loveren H., Maurer Th., Riecke K., Ullmann L., Ulrich P., Vandebriel R., Vohr H.-W. (2005): An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay 2nd round. Toxicology, 212, 69–79.
Ulrich P., Streich J., Suter W. (2001): Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals. Archives of Toxicology, 74, 733-744.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- The test item 2-Ethylimidazole was not a skin sensitiser under the test conditions of this study.
- Executive summary:
In this study the test item 2-Ethylimidazole was assessed for its skin sensitising potential using the Local Lymph Node Assay (LLNA, OECD 429) in mice. Test item solutions at different concentrations were prepared in the vehicle methyl ethyl ketone (MEK).
The LLNA is recommended as an animal test for predicting skin sensitisation in humans and provides a rational basis for risk assessment. The basic principle underlying the LLNA is that sensitisers induce a primary proliferation of lymphocytes in the lymph node draining the application site. The ratio of proliferation in test item treated groups compared to that in vehicle controls is termed the Stimulation Index (S.I.). Radioactive labeling is used to measure cell proliferations.
For this purpose a LLNA was performed using test item concentrations of 10, 25, and 50% (w/w). The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation (as determined by a pre-experiment).
The animals showed neither signs of systemic toxicity nor mortality during the course of the study. On day 3 and 4, a slight erythema of the ear skin (score 1) was observed in the animals treated with 50% of the test item. A statistically significant or biologically relevant increase in ear weights was not observed in any treated group in comparison to the vehicle control group. Furthermore, for BALB/c mice, a cut-off value of 1.1 for the ear weight index was reported for a positive response regarding ear skin irritation. None of the indices determined for the test item treated groups exceeded this threshold.
A test item is regarded as a sensitiser in the LLNA if exposure to one or more test item concentration results in a 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated test item concentration required to produce a S.I. of 3 is referred to as the EC3 value.
In this study Stimulation Indices (S.I.) of 1.06, 1.59 and 2.24 were determined with the test item at concentrations of 10, 25, and 50% (w/w) in MEK, respectively. A clear dose response was observed.
Although a statistically significant increase in DPM value and also in lymph node cell count and lymph node weights was observed in the highest dose group in comparison to the vehicle control group, this was not considered to be biologically relevant as the S.I. determined for this concentration did not exceed the threshold value of 3. Furthermore, the cut-off value of 1.55 for a positive response regarding the lymph node cell count index reported for BALB/c mice was slightly exceeded in the high dose group (index of 1.61).
The test item 2-Ethylimidazole was thus not a skin sensitiser under the test conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.